CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	120,275	55,169	86,022	97,707	100,932	94,800
Market Cap Growth	132.88%	-35.87%	-11.96%	-3.19%	6.47%	-18.19%
Enterprise Value	111,976	45,415	74,600	84,557	88,212	87,594
Last Close Price	10.52	4.65	6.73	7.30	7.35	6.77
PE Ratio	27.17	11.98	13.30	14.19	14.67	15.47
Forward PE	18.75	9.76	12.05	13.86	15.70	15.49
PS Ratio	4.20	1.79	2.48	2.79	2.95	3.20
PB Ratio	3.16	1.53	2.23	2.73	3.07	3.46
P/TBV Ratio	3.62	1.76	2.53	3.08	3.24	3.68
P/FCF Ratio	-	20.58	30.56	15.99	25.49	14.83
P/OCF Ratio	-	11.43	18.68	11.33	17.73	11.84
PEG Ratio	2.11	1.10	1.30	0.76	1.25	1.03
EV/Sales Ratio	3.91	1.47	2.15	2.42	2.58	2.96
EV/EBITDA Ratio	18.50	6.62	8.53	9.83	10.31	11.98
EV/EBIT Ratio	24.60	7.95	9.65	11.07	11.50	13.48
EV/FCF Ratio	-	16.94	26.50	13.83	22.27	13.70
Debt / Equity Ratio	0.01	0.02	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.09	0.08	0.09	0.08	0.01	0.05
Debt / FCF Ratio	-	0.20	0.28	0.11	0.03	0.06
Net Debt / Equity Ratio	-0.26	-0.25	-0.37	-0.44	-0.42	-0.39
Net Debt / EBITDA Ratio	-1.70	-1.34	-1.65	-1.84	-1.61	-1.46
Net Debt / FCF Ratio	-	-3.42	-5.11	-2.59	-3.47	-1.67
Asset Turnover	-	0.64	0.71	0.81	0.86	0.89
Inventory Turnover	-	2.78	3.26	3.45	3.10	2.85
Quick Ratio	-	1.95	2.32	2.39	2.47	2.22
Current Ratio	-	2.27	2.63	2.67	2.81	2.53
Return on Equity (ROE)	-	12.60%	18.22%	21.32%	22.79%	24.54%
Return on Assets (ROA)	-	7.40%	9.96%	11.04%	12.05%	12.13%
Return on Invested Capital (ROIC)	13.02%	17.69%	29.11%	33.40%	34.94%	31.93%
Return on Capital Employed (ROCE)	-	15.40%	19.40%	20.60%	22.70%	23.00%
Earnings Yield	3.69%	8.35%	7.52%	7.05%	6.82%	6.46%
FCF Yield	-	4.86%	3.27%	6.26%	3.92%	6.74%
Dividend Yield	2.47%	5.59%	4.22%	2.96%	2.54%	1.88%
Payout Ratio	-	74.72%	46.42%	34.42%	30.16%	29.61%
Buyback Yield / Dilution	2.93%	1.14%	0.38%	0.29%	0.01%	0.00%
Total Shareholder Return	5.40%	6.73%	4.60%	3.25%	2.55%	1.88%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.